Voters should care about this bill because it aims to tackle two major issues: economic development in struggling communities and securing the supply chain for essential medical products. If passed, it could lead to the creation of new manufacturing jobs in areas that desperately need them, offering opportunities and boosting local economies. This means a direct impact on people's livelihoods and local tax bases in specific communities.

Furthermore, by encouraging the domestic production of medical drugs and devices, the bill seeks to reduce America's reliance on foreign manufacturers. This could make the supply of critical medicines and equipment more stable, especially during global crises or pandemics, reducing the risk of shortages that directly impact public health. If it doesn't pass, the incentives to move manufacturing to distressed areas or bring it back to the U.S. might not materialize, potentially leaving communities without these job opportunities and the nation more vulnerable to disruptions in the global medical supply chain.